Peter Andre is the epitome of a family man but in a new interview, the star has made a surprising announcement about the future of his household with wife Emily MacDonagh, 35, and five kids. The ...

Comedian Peter Kay's tour raked in a whopping £27million last year. His Better Late Than Never string of dates has been named one of the most globally successful tours of 2024. The 51 year old ...

Peter Andre has made a big decision about expanding his family after welcoming his latest child aged 51. The Mysterious Girl singer and wife Emily MacDonagh welcomed their third child, Arabella ...

Peter Andre is back from Australia after spending some quality time with his parents. Since arriving back in the UK, the Mysterious Girl singer has been busy with more filming but it means he ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era. But even as the billions pile up, Regeneron isn't entirely happy with ...

Regeneron reported Q4 2024 earnings today - revenues were up 10% YoY to $3.79bn. Full-year revenues were up 8% to $14.2bn. Q4 GAAP EPS at $8.06, and $38 adj. full-year. The company declared its ...

Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...

As for revenue, Regeneron reported it at $3.79 billion for the fourth quarter, which was up 10% year over year. The company's full-year haul came in at $14.2 billion, which was an increase of 8%.

Biotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 10.3% year on year to $3.79 billion. Its non-GAAP profit of $12.07 ...

Regeneron has started 2025 with an increase in defensive capital allocation - initiation of a dividend and an expanded share buyback program. Increased competitive pressure on the Eylea franchise ...

It notched a convincing beat on net income. The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) net income didn't rise as ...